Skip to content
Home/GPs/Astorg
Astorg

Astorg

Paris, France·astorg.com
AUM
€23.0B
Funds
10
vintages 1999–2024
Portfolio
35
Exits
43

Key facts

HQParis, France
Websiteastorg.com

Recent exits

Clario
Healthcare · 2026 · 10yr hold
Anaqua
TMT · 2025 · 6yr hold
Acturis
TMT · 2024 · 5yr hold
Normec
Business Services · 2024 · 4yr hold

Coverage notes

10 funds tracked, 78 portfolio companies (35 active · 43 realized). Verified weekly from public filings and deal announcements.

Funds & portfolio

Every fund Astorg has raised, with its portfolio companies. Hand-checked from public filings.

10 funds
Astorg Normec Continuation FundBuyout
2024 · 2yr€1.4B1 active

Unrealized

1 held
NormecActive
Business ServicesNetherlands· Entry 2024
Astorg VIIIBuyout
2023 · 3yr€4.4B10 active

Unrealized

10 held
ActurisActive
TMTFrance· Entry 2024
Business ServicesFrance· Entry 2023
MedTechUnited States· Entry 2024
IPLActive
HealthcareFrance· Entry 2026
IndustrialsFrance· Entry 2025
HealthcareUS· Entry 2024
RedslimActive
TMTFrance· Entry 2025
SoficoActive
TMTFrance· Entry 2024
SolabiaActive
IndustrialsFrance· Entry 2025
HealthcareUnited States· Entry 2026
Astorg Mid-CapBuyout
2022 · 4yr€1.3B10 active

Unrealized

10 held
IndustrialsFrance· Entry 2022
AttikonActive
Business ServicesFrance· Entry 2025
AvaniaActive
HealthcareFrance· Entry 2022
BarkeneActive
Business ServicesFrance· Entry 2026
HealthcareFrance· Entry 2022
EcoVadisActive
TMTFrance· Entry 2022
HealthcareFrance· Entry 2023
IPCOMActive
Business ServicesFrance· Entry 2022
HealthcareFrance· Entry 2022
SteliauActive
Business ServicesFrance· Entry 2024
Astorg IQ-EQ Continuation FundBuyout
2022 · 4yr€1.3B1 active

Unrealized

1 held
IQ-EQActive
Business ServicesLuxembourg· Entry 2022
Astorg VIIBuyout
2019 · 7yr€4.2B11 active · 4 realized

Unrealized

11 held
CorialisActive
IndustrialsBelgium· Entry 2021
CorsearchActive
TMTFrance· Entry 2021
CytelActive
HealthcareFrance· Entry 2021
DemetraActive
HealthcareFrance· Entry 2021
FenergoActive
TMTFrance· Entry 2021
LGCActive
HealthcareFrance· Entry 2020
NemeraActive
HealthcareFrance· Entry 2019
Opus 2Active
TMTFrance· Entry 2021
SolinaActive
Business ServicesFrance· Entry 2021
Business ServicesFrance· Entry 2021
XceptorActive
TMTFrance· Entry 2021

Realized

4 exits
ActurisExited 2024
TMTFrance· Entry 2019
GP-ledto
AnaquaExited 2025
TMTFrance· Entry 2019
Secondaryto
IQ-EQExited 2022
Business ServicesFrance· Entry 2022
GP-ledto
NormecExited 2024
Business ServicesNetherlands· Entry 2020
GP-ledto
Astorg VIBuyout
2016 · 10yr€2.1B2 active · 8 realized

Unrealized

2 held
EchosensActive
HealthcareFrance· Entry 2018
IndustrialsFrance· Entry 2018

Realized

8 exits
Aries AllianceExited 2020
IndustrialsFrance· Entry 2018
Trade Saleto
AudiotonixExited 2020
TMTFrance· Entry 2017
Secondaryto
AutoFormExited 2021
TMTFrance· Entry 2016
Secondaryto
ClarioExited 2026
HealthcareUS· Entry 2016
Trade Saleto
FlowbirdExited 2021
TMTFrance· Entry 2016
Secondaryto
HRA PharmaExited 2021
HealthcareFrance· Entry 2016
Trade Saleto
IQEQExited 2022
Business ServicesFrance· Entry 2016
GP-ledto
Surfaces GroupExited 2020
IndustrialsFrance· Entry 2017
Secondaryto
Astorg VBuyout
2011 · 15yr€1.1B0 active · 7 realized

Realized

7 exits
KerneosExited 2017
IndustrialsFrance· Entry 2014
Trade Saleto
LinxensExited 2018
IndustrialsFrance· Entry 2011
Trade Saleto
M7 GroupExited 2019
TMTFrance· Entry 2014
Trade Saleto
MegadyneExited 2018
IndustrialsFrance· Entry 2014
Secondaryto
Metrologic GroupExited 2018
TMTFrance· Entry 2015
Trade Saleto
SaverglassExited 2016
IndustrialsFrance· Entry 2011
Secondaryto
SebiaExited 2018
HealthcareFrance· Entry 2014
Secondaryto
Astorg IVBuyout
2007 · 19yr€800M0 active · 9 realized

Realized

9 exits
EthypharmExited 2016
HealthcareFrance· Entry 2007
Secondaryto
Gras SavoyeExited 2015
Business ServicesFrance· Entry 2009
Trade Saleto
MetalorExited 2016
IndustrialsFrance· Entry 2009
Trade Saleto
OGFExited 2013
Business ServicesFrance· Entry 2007
Secondaryto
PhotonisExited 2011
IndustrialsFrance· Entry 2008
Secondaryto
SCTExited 2011
TMTFrance· Entry 2007
Secondaryto
SebiaExited 2014
HealthcareFrance· Entry 2010
TrescalExited 2010
Business ServicesFrance· Entry 2007
Secondaryto
WebhelpExited 2011
Business ServicesFrance· Entry 2007
Secondaryto
Astorg IIIBuyout
2003 · 23yr€300M0 active · 6 realized

Realized

6 exits
CISExited 2006
Business ServicesFrance· Entry 2004
Trade Saleto
GeoservicesExited 2010
Business ServicesFrance· Entry 2005
Trade Saleto
MecathermExited 2006
IndustrialsFrance· Entry 2003
Secondaryto
OndulineExited 2017
IndustrialsFrance· Entry 2006
Secondaryto
SebiaExited 2010
HealthcareFrance· Entry 2006
StaciExited 2014
Business ServicesFrance· Entry 2006
Secondaryto
Astorg IIBuyout
1999 · 27yr€185M0 active · 9 realized

Realized

9 exits
AnimalisExited 2003
ConsumerFrance· Entry 1999
Cerba HealthcareExited 2006
HealthcareFrance· Entry 2002
Secondaryto
Frans BonhommeExited 2003
Business ServicesFrance· Entry 2000
Secondaryto
LowendalExited 2004
Business ServicesFrance· Entry 2001
Secondaryto
PicardExited 2004
ConsumerFrance· Entry 2001
Secondaryto
Pizza PinoExited 2008
ConsumerFrance· Entry 1999
MBOto
RLDExited 2006
Business ServicesFrance· Entry 1999
Secondaryto
SebiaExited 2006
HealthcareFrance· Entry 2001
Secondaryto
Un Jour AilleursExited 2006
ConsumerFrance· Entry 2002
Secondaryto
Track Astorg

Saved GPs appear in your watchlist, one click from your workspace.

About Astorg

Astorg is a leading European mid-market private equity firm with €23.0 billion of assets under management as of December 2024, headquartered in Paris with offices in London, Luxembourg, Milan, Munich, New York and Frankfurt. The firm was founded in 1998 as a spinoff from Suez Group, becoming partner-owned and independent through subsequent management transitions. Astorg focuses on building lasting global leaders in selected sectors through majority and significant minority equity investments, typically held for five to seven years across successive flagship fund vintages.

Investment thesis

Astorg targets European mid-market and upper-mid-market companies with €300 million to €2 billion in enterprise value, deploying equity tickets between €150 million and €700 million per transaction. The firm's sector focus has consolidated around B2B services, healthcare, technology and selected industrial niches, with dedicated sector teams driving thematic origination and value creation. Astorg also operates complementary strategies including Mid-Cap and Co-Investment vehicles, plus a continuation-fund capability to extend ownership of high-conviction assets beyond traditional fund duration.

Recent activity

Recent realised exits include Clario (healthcare, 2026), Anaqua (TMT, 2025), Acturis (TMT, 2024) and Normec (business services, 2024), reflecting active distribution momentum across the healthcare and software franchises. The platform tracks 10 funds, 34 active portfolio companies and 44 realised exits, with ongoing deployment from the latest flagship vintage across European target geographies. Detailed buyer names and multiple data available on Pro at €29/month.

Last updated June 2026 · Sourced from public filings